Annual Report

Overview

The report describes a strong FY25, with revenue reaching ₹2,687 million and profitability improving through disciplined execution. The company completed the acquisition of Yash Pharma's India and Bhutan business, expanding its dermatology and childcare portfolio. Its women-focused CSR programme constructed four girls' toilets in Uttarakhand and Punjab, benefiting approximately 2,330 people. Environmental disclosures are limited because the company does not operate a manufacturing facility.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services